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Delivering the Lee Silverman Voice Treatment (LSVT) 
by web camera: A pilot study 
 
Abstract 
Background: Speech disorders are a feature of Parkinson’s disease, typically 
worsening as the disease progresses.  The Lee Silverman Voice Treatment 
(LSVT) was developed to address these difficulties.  It targets vocal loudness as 
a means of increasing vocal effort and improving co-ordination across the 
subsystems of speech.   
Aims: Currently LSVT is not widely available, and there are practical difficulties 
associated with the delivery of an intensive treatment in an environment of 
resource constraints in the NHS.  Delivery of LSVT over the Web may address 
some of these difficulties.   
Method: We report a feasibility study in which three individuals with speech 
disorders resulting from Parkinson’s disease received LSVT over the Internet, 
using broadband connection and a web camera.  Participants were seen face to 
face for every fourth session in order to build a personal relationship, measure 
vocal sound pressure level (SPL) during treatment and to review and prepare 
homework tasks.  All other sessions were delivered over the Internet. 
Results: Broadly similar treatment gains were found between individuals treated 
over the Internet and those treated face to face (Ramig et al, 2001a).  Gains 
were maintained or improved at an assessment 2 months after the treatment.  
Conclusion:  This feasibility study demonstrates that delivery of LSVT over the 
Internet may be both cost and treatment effective, and that a larger trial would be 
appropriate. 
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What this Paper adds.  The Lee Silverman Voice Therapy (LSVT) was developed 
to improve the communication of people with dysarthric speech as a result of 
Parkinson’s disease.  Although there is evidence for its effectiveness, the 
intensive nature of the treatment presents difficulties for clinicians and clients.  
This paper presents a feasibility study of the delivery of LSVT over the Internet.  
The results for three participants are comparable with those obtained with face-
to-face delivery.  We conclude that a larger study of the delivery of LSVT over the 
Internet would be appropriate. 
 
 
Key Words: Parkinson’s disease, Dysarthria, Lee Silverman Voice Treatment, 
Internet therapy delivery.
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Hypokinetic dysarthria is a common feature of Parkinson’s disease.  Logemann 
et al (1978) report that the majority of patients with Parkinson’s disease will 
present with speech problems at some stage of the disease.  Duffy (2005) 
describes the features of hypokinetic dysarthria.  At the perceptual level these 
include a weak, breathy, hoarse or harsh vocal quality, reduced loudness, a 
variable rate of speech including inappropriate silences and a reduction or 
absence of facial expression.  Ho et al (1998) found that voice was the most 
frequently affected speech characteristic in a large sample of patients.  Reduced 
volume is a common characteristic of parkinsonian voice (Fox and Ramig, 1997; 
Ho et al 1999).  Physiological changes include irregular vocal fold activity, vocal 
fold bowing and increased rigidity and reduced speed and range of the laryngeal 
musculature (Smith et al., 1995). 
 
These features may vary because of the progressive nature of the disease.   
Schulz and Grant (2000) state that depression, cognitive decline and medication 
may also contribute to this variability but they observe no clear relationship 
between duration and the severity of the dysarthria.  Goberman and Coelho 
(2002) in their review of the speech changes associated with medication, and 
Pinto et al (2004), observe that pharmacological and neurosurgical treatments 
improve tremor, dyskinesia and muscle rigidity but have uncertain effects on 
speech. 
 
Commonly patients with Parkinson’s disease underestimate their problems (Ho 
et al, 2000; Yorkston et al, 2004) and are often reluctant to raise their voices to 
improve intelligibility, believing that they are speaking too loudly (Fox et al, 2002; 
Liotti et al, 2003).  This suggests that the voice disorder may be compounded by 
an impaired perception of its true severity.  In a study of how voice and speech 
changes affect communication, Miller et al (2006) found difficulties initiating and 
maintaining a conversation, including formulating thoughts and maintaining 
attention.  They also state that feelings of exclusion from the reactions and 
behaviours of others can reduce confidence and self esteem.   
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Until recently there was little evidence that speech and language intervention 
was effective for individuals with Parkinson’s disease.  This, the progressive 
nature of the disease and a failure to generalize gains made in treatment were 
reflected in low referral rates.  Mutch et al (1986) found that 65% of patients 
reported speech problems but only 4.4% had been referred for speech therapy.  
In a survey in Sweden, Hartelius and Svensson (1994) found that 70% reported 
impairment to their speech but only 3% had received speech therapy. 
 
When offered, therapy typically targeted respiratory function to improve support 
for speech, treatment for phonation to improve vocal intensity, articulatory drills to 
improve precision and reduce rate, and prosodic therapies to improve the use of 
stress and intonation (see Yorkston et al 1988). Therapeutic devices used to 
improve intelligibility included amplification devices, delayed auditory feedback, 
biofeedback and masking devices (Greene and Watson 1968; Downie et al, 
1988).  Treatment intensity appears to be important.  Robertson and Thompson 
(1984) noted improvements after two weeks of intensive group therapy, which 
were maintained twelve weeks later.  Johnson and Pring (1990) reported gains 
following ten hours of therapy delivered over four weeks but longer-term benefits 
were not assessed.  
 
Recently stronger evidence has been reported by researchers using the Lee 
Silverman Voice Treatment (LSVT) (Fox et al, 2006).  Drawing on techniques 
from motor speech and voice disorders, LSVT addresses the needs of individuals 
with Parkinson’s disease by focusing on vocal loudness as a means to increase 
vocal effort and improve co-ordination across the subsystems of speech.  
Treatment uses speech tasks to target phonation and to improve the quiet, 
monotonous speech resulting from decreased drive to the respiratory and 
laryngeal musculature (Fox et al, 2002).  Improved efficiency of the phonatory 
source improves vocal fold adduction and laryngeal muscle function and so 
increases respiratory support for speech (Dromey et al, 1995; Smith et al 1995).  
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LSVT simultaneously addresses the sensory characteristics of Parkinson’s 
disease evident in difficulties transferring gains from the clinic environment into 
everyday life.  This is achieved through a combination of intensity of treatment 
and feedback to develop the association between increased vocal effort and 
improved speech intelligibility (Kleinow et al 2001).  Studies show LSVT to be 
more effective than respiratory-only therapies in improving loudness and pitch 
variation and at maintaining these changes two years later (Ramig et al 1995, 
2001b).  In a study comparing sound pressure levels in treated and untreated 
groups (Ramig et al, 2001a), the latter improved by 5.5 dB after treatment and by 
3.7 dB 6 months later on a task where they spoke freely on a chosen topic 
(‘monologue’ task).  The clinical significance of this result may be gauged by the 
finding of a difference of 2.9 dB between the treated group and age matched 
healthy controls before treatment. 
 
Improvements have also been found in articulation, prosody, vocal quality and 
intelligibility (Dromey et al, 1995; Ramig et al, 1995, 1996, 2001a, 2001b; 
Countryman et al, 1997; Baumgartner et al, 2001; Sapir et al 2007).  This 
evidence is based on a treatment delivery for four days a week across four 
weeks, supplemented by additional home practice.  The rationale is that 
individuals can compensate for deficits through a programme of high effort and 
intense training to enable a re-scaling of the effort required to produce an 
adequate level of loudness (Ramig et al 1995).   Further, evidence suggests that 
LSVT does not adversely affect voice quality or induce vocal strain (Smith et al. 
1995; Ramig et al, 1996; Baumgartner et al, 2001). 
 
In the UK, the National Institute for Health and Clinical Excellence (NICE) and the 
National Collaborating Centre for Chronic Conditions (2006) comment that 
evidence for LSVT is good but based on small samples.  Studies with well 
defined inclusion criteria, uniform assessment tasks and outcome measures are 
required.  The NICE guidelines also express concerns about the delivery of an 
intensive therapy requiring sixteen hours of treatment across four weeks in the 
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current climate of resource constraints within the NHS.  Issues include clinician 
time (with regard to those working across multiple geographical sites or on part-
time contracts), transportation availability and cost, and client convenience and 
motivation. 
 
This problem of resource constraints has suggested alternative models of 
delivery.   A study of an extended programme of delivery (2 days per week for 8 
weeks) yielded mixed results (Spielman et al, 2007).  Increases in vocal sound 
pressure levels were comparable to previous studies but barriers to 
implementation were noted.  The present paper takes an alternative approach.  
An intensive regime (4 sessions a week) is used by returning to the more 
intensive approach but offering sessions of treatment delivered across the 
Internet using a web cam.  Initial data on three patients are presented. 
 
Therapy across the Internet is in its infancy and research on its effectiveness is 
limited.  The term ‘telepractice’ was adopted by the American Speech-Language-
Hearing Association to describe the delivery of therapy across distances (ASHA 
2001).  In its broadest definition ‘telepractice’ includes all interactions conducted 
via a telecommunications medium rather than face-to-face.  However, the advent 
of Internet based technologies with their improved quality of signal and speed 
and potential cost savings greatly surpasses previous means of providing remote 
therapy.  A key benefit is improved patient access to specialist services without 
regard for geographical boundaries, thereby both increasing patient choice and 
optimising the use of professional expertise (Brinegar and McGinley 1998).  For 
those with mobility problems, electronic access may address service delivery 
limitations.  It offers travel cost savings (for patients and professionals) and may 
reduce the number of cancelled appointments (ASHA 2005).  In terms of the 
quality of the service for users, home based therapy sessions offer a familiar 
comfortable environment and enable professionals to treat in functional settings.  
For some individuals the technology can enhance their treatment, increasing 
interest levels and motivation (Brennan et al, 2002). 
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Critics have argued that effective intervention in speech and language therapy 
requires accurate auditory and visual information acquired through face to face 
interaction (Hill and Theodoros, 2002) and concerns have been raised that 
remote delivery may be used to reduce costs and thereby diminish standards of 
care (Brinegar and McGinley 1998).  ASHA (2005) cites criticisms of the lack of 
face-to-face contact precluding the use of tools such as tactile manipulation to 
facilitate cueing.  Maintaining eye contact may pose difficulties and treatment 
activities may be restricted due to the fixed positioning of the equipment (ASHA 
2005). 
 
Recent studies have examined the technological feasibility of remote therapy 
with a variety of clients or have compared outcomes of small samples receiving it 
with outcomes after face-to-face interventions (Mashima et al, 1999; Georgeadis 
et al, 2004; McCullough, 2001; Theodoros et al, 2003).  More recently Theodoros 
et al (2006) investigated the feasibility and efficacy of delivering LSVT using 
Internet based video conferencing technology to individuals with speech 
problems as a result of Parkinson’s disease who were situated in a different 
room.   
 
ASHA (2005) summarises candidacy issues to include difficulties for patients with 
bilateral motor impairments, visual and hearing difficulties, sitting tolerance, 
linguistic/cultural issues, severe cognitive impairments and/or attention deficits 
influencing the ability to engage with the therapist or manage the equipment in 
distance interactions.  ASHA also notes that the availability of third party, on-site 
support for the patient may also influence candidacy (ASHA 2005).   Brennan et 
al (2002) highlight technophobia and the degree of the user’s previous 
experience and confidence with the technology as issues and Mashima et al 
(2003) say that remote delivery may be more appropriate as a means of 
facilitating generalisation and maintenance rather than assessment and 
treatment. 
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Patient and clinician satisfaction with remote delivery is an important issue.  
Whilst responses in the literature have been largely positive (Georgeadis et al 
2004, Mashima et al 2003, Theodoros et al 2006), ASHA (2005) say that user 
satisfaction must be measured separately from therapy outcomes.  A possible 
indication of clinician satisfaction is the finding in a survey by ASHA (2002) that 
9% of its members were already offering services remotely and that 47% were 
interested in doing so. 
 
Despite the studies above, the efficacy of remote delivery has not been fully 
demonstrated.  Hill and Theodoros (2002) point out that studies are of a limited 
number of communication disorders and that a more structured and scientific 
approach to study design and implementation is required to facilitate replications.   
Theodoros et al (2006) found Internet based delivery of LSVT to be both feasible 
and effective with ten individuals with Parkinson’s disease, and identify the need 
for a larger study to validate their findings.  Consistent transmission quality (audio 
and visual) is required to evaluate clinical outcomes and user satisfaction 
(Georgeadis et al 2004).  Cost-benefit analyses of remote treatment are required 
so that efficacy is not sacrificed in the pursuit of cost cutting or faster treatment 
procedures. 
 
Delivery of LSVT over the Internet may overcome difficulties posed by the need 
for intensive treatment in an environment of resource constraints.  Using a web 
cam via broadband connectivity, individuals with speech problems as a result of 
Parkinson’s disease may be treated remotely in a location of their choice 
 
This study examines the feasibility of using a web camera to deliver LSVT and 
compares the outcomes with clients treated face to face by Ramig et al (2001a) 
Method 
Three participants with speech disorders resulting from idiopathic Parkinson’s 
disease were recruited via referrals to the Motor Speech Disorders Clinic at City 
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University.  Participants had to be familiar with IT applications within a Microsoft 
Windows desktop environment and to possess the necessary equipment within 
their home.  The first three referrals to meet these criteria were recruited.  
Participation was voluntary with no payment of expenses.  Participants were 
male, aged between 63 and 72 years and had been diagnosed between three 
and six years previously.  The Frenchay Dysarthria Assessment (Enderby, 1983) 
was used to confirm a profile of voice and speech impairment consistent with 
mild to moderate hypokinetic dysarthria.  Each had a stable medication regime. 
Technology  
Participants needed a computer with a 1GHz processor, 256 MB RAM and at 
least 50 MB of free disk space on the hard drive, with a Windows XP operating 
system, a broadband connection to the Internet and a web cam with headset and 
microphone.  They required Windows Media Player on the computer, an account 
with Skype (a peer to peer Internet telephony network), and email contact with 
the clinician. 
 
It was anticipated that differences in skill level, equipment configuration and 
transmission quality might influence treatment delivery.  Prior to the start of 
treatment each participant had one or more remote practice sessions with the 
therapist to check that Skype had been correctly downloaded and that account 
details were accurate and to identify possible environmental or technical 
difficulties and/or skill deficits.  
Treatment  
Each participant completed sixteen hours of intensive therapy (as described by 
Ramig et al, 2001a) delivered 4 times per week for 4 weeks.  One session each 
week was delivered face to face, in participants’ homes.  This was done in order 
to build a personal relationship, to objectively measure sound pressure levels 
during treatment, to review weekly homework sheets and to deliver tailored 
materials to support the transition of high effort in speech tasks from short 
phrases to longer reading and conversation tasks.  Other sessions were 
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delivered over the Internet.  Clearly, the need for face to face sessions means 
that delivery of therapy was not fully remote; however, for convenience we will 
refer to our therapy as remote and contrast it with the face to face therapy 
assessed in Ramig et al (2001a). 
 
Treatment was delivered to established LSVT principles by a clinician certified in 
LSVT (Ramig et al 1995, 1996, 2001a, 2001b).  Speech drills comprising 
maximum duration ‘ah’ phonation, maximum fundamental frequency range and 
personal phrases occupy the first half of each session.  Stimulated behaviours 
from these drills are then directly applied in speech tasks for the remainder of the 
session.  Over the course of treatment these comprise a hierarchy of spoken, 
reading and conversation tasks.  Daily homework tasks encourage continued 
intensity of effort and facilitate carryover into everyday communication.  
Instrumentation 
During face-to-face sessions sound pressure levels were measured using a 
Radio Shack digital output sound level meter placed 30cms from the participant’s 
mouth.  It was not possible to accurately measure db SPL during web cam 
sessions.  Approximate measures were obtained by placing the meter at a 
constant distance to the sound speaker, with the volume of the PC set at a 
constant level across each session.   
 
Pitch was measured to monitor treatment and provide feedback using a Seiko 
Chromatic Tuner in both face to face and web cam sessions.  Duration was 
measured using a stopwatch in face-to-face sessions.  A digital stopwatch was 
downloaded for web cam sessions and operated by mouse control. 
 
Voice recordings were made for feedback purposes.  In face-to-face sessions 
these were made using an Olympus Digital Voice Recorder.  Recordings were 
discussed during the session and transferred and saved to the clinician’s PC.  
Examples were sent to participants as email attachments to illustrate target 
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behaviour and support home practice.  During web cam sessions voice 
recordings were made using HotRecorderTM which allows users to record 
conversations during Skype calls and play and/or save recorded files.   
 
Safeguarding privacy and confidentiality during the electronic transfer and 
storage of information was addressed at a number of levels.  Firstly assessment 
took place in face to face settings prior to the treatment programme and medical 
information was not exchanged during therapy sessions over the Internet.  
Secondly information exchanged over the Skype network is encrypted, enabling 
a higher level of security than ISDN or conventional analogue systems (including 
the telephone network).  Thirdly recordings made during the therapy sessions 
became the property of the participating individuals.  Further, the management of 
secure network requires a computer fitted with state of the art anti spyware and 
anti virus software that is regularly updated. 
 
Design 
Data were collected two weeks prior to therapy, at the start and end of therapy 
and two months after its completion by the treating speech clinician.  The 
assessment protocol followed that in Ramig et al (2001a) and consisted of three 
trials of sustained phonation “ah”, reading the ‘Rainbow Passage’ (Fairbanks 
1960) and speaking freely on a self-chosen topic for one minute (monologue).  
Data were compared with that in Ramig et al (2001a). 
 
Assessment: data collection and analysis 
Pre and post treatment recordings were made using a PDR1000TC Portable 
Timecode DAT recorder with a Sony ECM-MS957 Electret Condenser 
Microphone placed 30cm from the mouth.   Recordings were re-digitised at a 
sampling rate of 48 KH using the Computerised Speech Lab (Kay Elemetrics, 
Kay Pentax, Model 4150) in order to be analysed. 
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SPL dB measurements were calculated by an examiner blind to the pre and post 
therapy conditions.  The peak data points from each sample were used.  For the 
sustained phonation task, the second of the three samples of the vowel “ah” was 
analysed.  Peak decibels were also measured for reading the ‘Rainbow Passage’ 
and for sixty seconds of connected speech from the monologue task. 
 
It was not possible to collect data under the same recording conditions as the 
comparison data (Ramig et al, 2001a).  In the absence of a sound treated booth 
data were collected face to face in a quiet room in the participants’ homes. 
 
Results 
Table 1 gives the mean results of the 3 participants and of the 14 participants 
treated face to face in Ramig et al (2001a).  Note that in that study there are no 
data for two weeks prior to therapy as reported here (Ramig et al. report only the 
mean value for three measures taken in the two weeks prior to therapy) and that 
the follow up data are from an assessment 6 months not 2 months after therapy. 
 
Insert Table 1 about here. 
The scores for the participants in this study change very little across the 2 pre- 
therapy assessments and are remarkably similar to the mean pre- therapy 
performance of the participants in Ramig et al (2001a).  The improved scores 
post therapy are also very similar.  Table 2 illustrates this by giving the difference 
between the scores here and in Ramig et al (2001a) in standard deviations (i.e. it 
treats the latter as a normative sample).  This shows the pre and post therapy 
mean scores in the present study are within half a standard deviation of the 
scores Ramig at al (2001a).  However, the follow up scores of remotely treated 
participants are considerably higher than those of patients treated face to face. 
Insert Table 2 about here. 
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An analysis of variance on the scores of the remotely treated patients confirmed 
that they had made significant progress with time (F (3, 6) = 8.50, p = .01) and 
planned comparisons confirmed that the effect was due to the improvement in 
loudness between the pre and the post therapy assessments.  A significant 
interaction between time and type of task was also found (F (6, 12) = 4.69, p = 
.01) indicating that the improvement with LSVT was strongest in the prolonged 
phonation (‘ah’) task. 
Discussion 
This feasibility study showed that individuals treated remotely with LSVT can 
achieve comparable gains to those treated face to face (Ramig et al, 2001a).  
Prior to therapy they recorded similar vocal sound pressure levels to those 
treated face to face.  The outcomes for the three participants both as a group and 
as individuals were comfortably within the distribution of scores of patients 
treated face to face. These findings are consistent with previous clinical research 
for the efficacy of LSVT in treating speech and voice disorders in individuals with 
PD (Fox et al 2002).  In particular, they may endorse the benefits of the intensive 
style of the treatment comprising high effort multiple task repetitions and 
quantification of treatment related changes to promote over learning and 
internalisation as prerequisites for independent generation and self monitoring of 
normal loudness levels (Trail et al 2005).  Improvements were seen in each of 
the assessment tasks but were most pronounced in the sustained phonation 
(‘ah’) task.  This is unsurprising in view of the fact that this task is repeatedly 
practiced during therapy.  A similar trend is seen, but not analysed, in the data 
obtained by Ramig et al (2001a, see table 1), by Spielman et al (2007) and by 
Theodoros et al (2006). 
 
A weakness in our design is that post therapy assessments were carried out by 
the treating clinician.  There is evidence that Parkinson patients can increase 
their volume in response to implicit cues (Ho et al 1999).  Although this situation 
is likely to occur in clinical work, it is desirable that a ‘blind’ assessor is used in 
research studies.  Ramig et al (2001a) do not state whether they used a blind 
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assessor; Spielman et al (2007) and Theodoros et al (2006) did do so.  Use of 
blind assessors is more inconvenient when assessments are carried out in 
participants’ homes.  Although future studies should use blind assessment, it is 
unclear whether this will remove bias.  It may be that the task itself cues the 
participant.  The assessment is objective and gives relatively little scope for bias 
by the assessor.  Treated participants, on the other hand will know that they are 
being assessed and respond accordingly. That they improve their sound 
pressure levels under such circumstances may be a poor indication of the 
volume they achieve in communication.  Assessment of the latter is more difficult 
but more revealing as to the success of treatment. 
 
A further weakness was that it was not possible to conduct assessments in a 
sound treated booth as in other experimental studies.  Transporting patients to 
such a facility would have largely negated the attraction of receiving therapy in 
their own homes.  This difference in procedure should be borne in mind when 
comparing across the studies.  In defence of our procedure, we note that our 
loudness levels were very similar to those in Ramig et al (2002a), that the 
assessment conditions in our study though different from other studies were 
consistent across the study.  The lack of a sound treated booth had no effect on 
the quality of the analysis and moreover, is likely to be a necessary consequence 
of remotely conducted LSVT. 
 
Remote delivery may not be suitable for all candidates.  Generic candidacy 
criteria for distance interactions has been summarised by ASHA (2005).  These 
include literacy, hearing and visual abilities and physical endurance determining 
sitting tolerance.  Studies of LSVT delivered face to face have indicated variables 
that impede successful outcomes.  In addition to underlying voice or speech 
disorders unrelated to Parkinson’s disease, these include moderate or severe 
dementia, depression, atypical Parkinsonism and neurosurgery for Parkinson’s 
disease (Trail et al 2005).   
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Candidacy criteria for remote therapy may need further consideration.  LSVT is 
appropriate for individuals with mild cognitive impairments in face-to-face 
settings.  Its single treatment goal and emphasis on modelling and repetition are 
helpful here (Fox et al 2002).  This benefit may not extend to individuals with 
attention and concentration deficits who may have difficulties engaging with a 
clinician via a monitor and small screen image.  Processing speed, memory and 
executive function deficits may impede the ability to follow directions and to 
manage desktop operations.  Indeed ASHA (2005) calls for candidacy to be 
assessed on a case-by-case basis. 
  
Lack of the required technology excluded some candidates from participating in 
this study.  Lack of familiarity with or experience of using it excluded others.  
Costs have been cited as a barrier to providing remote services.  These 
problems are also likely to diminish with time and will be less of an obstacle to 
accessing treatment.  Two of the three participants purchased new hardware and 
arranged broadband connections.  The third purchased a web cam.  This 
indicates a high level of motivation and financial commitment to the treatment 
that may distinguish the participants from others who could not take part.  It may 
be noted, however, that LSVT in its face-to-face form requires commitment and 
that expense of travel to receive it may be a financial disincentive. 
 
Reduced face-to-face contact is often seen as a cause of reduced standards of 
care in remote treatment.  In this study, developing a personal relationship with 
the participants and their spouses/partners was essential.  Participants were 
informally assessed in their homes at the outset of the study.  This, coupled with 
informal calls via Skype prior to therapy, enabled the clinician to assess desktop 
management skills, gauge family members’ responses to the arrival of video 
conferencing in their homes and build rapport.  During the study family members 
would frequently come to the computer before or during a session to seek 
information or advice.  Face to face meetings also took place at the start of each 
week of treatment to allow participants to become familiar with the next level of 
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the speech exercise hierarchy prior to the remote sessions.  These meetings also 
allowed objective measurement of loudness levels (measured in dB SPL).  This 
was not possible during remote sessions and so reduced the feedback normally 
available to participants.  Weekly face-to-face sessions provided a guide to 
change across each stage of treatment. 
 
There are clear advantages to delivering LSVT to clients in their own homes.  It is 
beneficial in terms of fatigue management and for those with reduced mobility.  
Participants are more relaxed, leading to a better rapport between clinician, client 
and family members.  Speech exercises are practised in the target environment. 
Uncontrolled environmental events and interruptions occurring during sessions, 
at first appeared a disadvantage.  In fact these gave the clinician an opportunity 
to see how the individual used their voice in context, and gave the individual an 
opportunity to reflect on the impact of loudness levels on those around them. 
 
Fear of technology is often cited as a barrier to improving treatment accessibility.  
Whilst this may inhibit some individuals, observation of the participants in this 
study left little doubt that they saw remote treatment as convenient and a novel 
and motivating delivery method.  Brennan et al (2002), in their study on remote 
treatment after stroke, also observed increased motivation and responsiveness 
as a result of the technology.  All the participants in this study commented that 
daily visits to a hospital would have precluded participation in a treatment 
programme. 
 
Participants received sound files containing recorded speech exercises via email.  
These recordings allowed them to review their performance in the sessions if 
desired.   After treatment, participants had recordings that could serve as a 
model for practice.  A notable feature of the results is that sound pressure levels 
further increased at the two-month follow up assessment.  This compares with a 
slight decline in the follow up data in Ramig et al (2001a).  Caution is needed in 
interpreting these data as the follow up here was conducted only two months 
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after treatment compared with six months in Ramig et al (2001a).  It is possible 
that the individuals treated face to face also made gains to this point before 
falling away by six months.  A possible explanation, however, is that remote 
treatment has contributed to continued improvement by promoting self reliance 
and providing a means of reviewing current performance against the sound 
recordings of their performance during therapy.  
 
During the study the quality of the audio and visual link was variable: at times the 
quality was excellent, at others the quality of the link was susceptible to 
deterioration.  Upgrading the broadband connection to a uniform 8 Mb per 
second for all users would be one way to improve line quality.  End to end audio 
delay was addressed by using a headset to override the audio link via the 
computer’s loudspeakers.  Optimum sound quality requires a high specification 
sound card and microphone, but averagely priced soundcards (such as 
SoundBlaster) achieved adequate sound definition during the study.  The quality 
of the HotRecorder sound files (recorded at 32 Kb per second) was adequate.  
Improvements may be achieved using alternative products recording at higher bit 
rates and/or using enhancement tools to amplify, normalise or remove hiss. 
 
The small number of participants in this pilot study prevents us drawing any 
general conclusion as to the efficacy of LSVT delivered remotely.  Such a 
conclusion must await a larger study.  Evaluation of such a study is required at 
both the outcome and the process levels.  It must determine whether outcomes 
for a large sample of individuals treated over the Internet matches those of 
individuals treated face to face.  This comparison will not be straightforward.  
There are patients who will benefit from LSVT but who are not suitable for remote 
treatment.  Comparisons of face to face and remote treatment should only be 
carried out for patients who meet the entry criteria for treatment across the 
Internet.  Currently these criteria are not fully defined.  There were too few 
participants in our study to define these criteria beyond the obvious: that they had 
to possess the necessary equipment and to be comfortable using it.  At the 
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process level, the technological specification described requires further large 
scale testing to evaluate the efficiency and cost effectiveness of this method of 
treatment.  Patient and clinician satisfaction should also be assessed to evaluate 
its impact on the quality of service delivery.  The present study shows that some 
patients can benefit from treatment across the Internet and that technical 
problems associated with it (for both client and clinician) can be overcome.  Its 
role has been to demonstrate that further research is appropriate.   
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Data from Ramig et al (2001a) 30cm dB SPL  
TASK  Pre  therapy 
(mean of 3 pre- 
assessments) 
Post therapy 6 month f up 
Ah  69.1     (5.1) 82.4     (3.9) 79.8   (3.7) 
Rainbow  71.3     (3.2) 77.9     (4.2) 76.1   (3.2)     
Monologue  69.0     (3.6) 74.5     (4.3) 72.7   (3.6) 
Data for remote therapy 30cm dB SPL 
TASK Pre  therapy 1 Pre  therapy 2 Post therapy 2 month f up 
Ah 67.3   (3.1) 67.7   (3.5) 82.0   (5.2) 85.3   (1.5) 
Rainbow 70.3   (1.1) 70.0   (1.1) 77.7   (5.5) 82.3   (5.5) 
Monologue 69.0   (3.6) 68.7   (3.4) 75.3   (10.2) 77.7   (8.9) 
Table 1.  Mean (and standard deviations) dB SPL for participants in Ramig et al 
(2001a) and for participants in the present study. 
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TASK Pre  therapy 1 Pre  therapy 2 Post therapy 2 month f up 
Ah -0.35 -0.27 -0.10 1.48 
Rainbow -0.31 -0.40 -0.04 1.93 
Monologue 0.0 -0.08 0.18 1.39 
Table 2. Comparison of remote and face-to-face scores in standard deviations.  
Pre therapy 1 and 2 are compared with the pre therapy scores and the 2 month 
follow up with the 6 month follow up in Ramig et al (2001a). 
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